未找到相关数据
Glitazones in the treatment of diabetes mellitus: clinical outcomes in large scale clinical trials
被引：4
作者：
Charbonnel, Bernard
[1
]
机构：
[1] Univ Hosp, Dept Endocrinol & Diabet, Nantes, France
关键词：
glitazones;
PROactive;
type 2 diabetes mellitus;
D O I：
10.1111/j.1472-8206.2007.00533.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Only one large scale cardiovascular outcome study has been completed and published for the thiazolidines-iones in type 2 diabetes, the PROactive study which demonstrates a strong trend in favour of a specific cardioprotective effect of pioglitazone. The other available data, published as meta-analyses, suggest that there is a difference in this regard between pioglitazone and rosiglitazone.
引用
收藏
页码：19 / 20
页数：2
相关论文